Log in to save to my catalogue

Alkannin Inhibited Hepatic Inflammation in Diabetic Db/Db Mice

Alkannin Inhibited Hepatic Inflammation in Diabetic Db/Db Mice

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_29554661

Alkannin Inhibited Hepatic Inflammation in Diabetic Db/Db Mice

About this item

Full title

Alkannin Inhibited Hepatic Inflammation in Diabetic Db/Db Mice

Publisher

Basel, Switzerland: S. Karger AG

Journal title

Cellular Physiology and Biochemistry, 2018-04, Vol.45 (6), p.2461-2470

Language

English

Formats

Publication information

Publisher

Basel, Switzerland: S. Karger AG

More information

Scope and Contents

Contents

Abstract
Background/Aims: The current study was designed to investigate the protective role of alkannin (ALK) on liver injury in diabetic C57BL/KsJ-db/db mice and explore its potential mechanisms. Methods: An oral glucose tolerance test (OGTT) was performed. The levels of insulin, alanine aminotransferase (ALT), aspartate aminotransaminase (AST)...

Alternative Titles

Full title

Alkannin Inhibited Hepatic Inflammation in Diabetic Db/Db Mice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_29554661

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_29554661

Other Identifiers

ISSN

1015-8987

E-ISSN

1421-9778

DOI

10.1159/000488264

How to access this item